埃莫德普西德:除草剂的作用方式和毒性
Charity N Njeshi1, Alan P Robertson1, Richard J Martin1
1Department of Biomedical Science, College of Veterinary Medicine, Iowa State University, Ames, IA, United States.
埃莫德普赛德在治疗人类线虫感染 (如虫病和虫病) 方面表现有前途,为抗药性提供了一个新的选择. 它的安全性和耐受性正在审查中,用于兽医和人类医学应用.
科学领域:
- 兽医医学 兽医医学 兽医医学
- 人类医学 人类医学 医学
- 寄生虫学的寄生虫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 尼马寄生虫感染给全球健康带来了重大挑战.
- 抗虫药物耐药性是一个日益关注的问题,需要新的治疗策略.
- 药物重新定位为发现新治疗方法提供了一种具有成本效益的方法.
研究的目的:
- 审查emodepside的药理动力学,安全性和耐受性.
- 评估埃莫德普西德在治疗人类线虫感染方面的潜在益处和风险.
- 为兽医和人类医学应用提供关于emodepside毒性的见解.
主要方法:
- 对emodepside的特性和临床试验的文献综述.
- 对药物动力学数据的分析.
- 检查安全性和毒性概况.
主要成果:
- 埃莫德普赛德是一种广泛的杀虫剂,对猫和狗有效.
- 它正在被试验到人类,三毛病和虫感染.
- 埃莫德普赛德具有独特的作用机制,与传统的杀虫剂不同.
结论:
- 埃莫德普赛德 (Emodepside) 是一个有前途的候选药物,可以对抗虫药物耐药性.
- 虽然证明了良好的安全性,但持续的毒性监测至关重要,特别是在脆弱人群中.
- 本综述作为一种资源,以了解emodepside在甲虫治疗中的作用.
更多相关视频
00:05In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
09:07Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
相关概念视频
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Direct-Acting Cholinergic Agonists: Pharmacokinetics
